CrushSCI.com
Journal Selection & Manuscript Polishing Services
Acta Neuropathologica Communications journal cover Medicine
Back to journal directory

Review Cycle Records

Acta Neuropathologica Communications

Springer SCIE OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
109.5Average days
108Median days
71Fastest days
200Longest days
2902025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

129 days

The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas

AuthorsHanna Gött; Jonas Tellermann; Hannes Becker; Christina Fodi; Peter Paßlack; Elgin Hoffmann; Maria Elisa Di Francesco; Daniel J. Merk; Jürgen Honegger; Ghazaleh Tabatabai; Marcos Tatagiba; Felix Behling; Jens Schittenhelm

Affiliations1. Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 2. Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 3. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 4. Cluster of Excellence (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, Eberhard-Karls University Tübingen, Tübingen, Germany; 5. Department of Anesthesiology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 6. Department of Radiation Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 7. Department of Ophthalmology, Inselspital Bern, University of Bern, Bern, Switzerland; 8. German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany; 9. Department of Neurosurgery, Faculty of Medicine, Augsburg University, Augsburg, Germany; 10. Translational Oncological Neurosurgery, Faculty of Medicine, University Augsburg, Augsburg, Germany; 11. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany

Source PDF DOI Publisher page
113 days

A standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases

AuthorsLeonie Sowoidnich; Aaron L. Norman; Florian Gerstner; Josiane K. Siemund; Jannik M. Buettner; John G. Pagiazitis; Vanessa Dreilich; Konstantin Pilz; Dajun Tian; Charlotte J. Sumner; Angela Paradis; George Z. Mentis; Christian M. Simon

Affiliations1. Carl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany; 2. Center for Motor Neuron Biology and Disease, Columbia University, New York, USA; 3. Depts. of Pathology and Cell Biology and Neurology, Columbia University, New York, USA; 4. Biogen, Cambridge, USA; 5. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 6. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA; 7. Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Source PDF DOI Publisher page
71 days

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation

AuthorsLazaros Lazaridis; Xiaomei Zhou; Raphael Bodensohn; Malte Mohme; Julia Onken; Regina von Manitius; Naomi Houedjissin; Tobias Blau; Ilinca Popp; Sarina Agkatsev; Sabine Seidel; Christina Schaub; Maximilian Scheer; Andre Sagerer; Volker Neuschmelting; Davide Tosin; Viktoria Ruf; Michael C. Burger; Christoph Oster; Teresa Schmidt; Benjamin Thiele; Jürgen Hench; Stephan Frank; Martin Stuschke; Laurèl Rauschenbach; Stephan Tippelt; Beate Timmermann; Kathy Keyvani; Clemens Seidel; Andrea Tannapfel; Dorothea Miller; Niklas Thon; Joachim P. Steinbach; Elke Pfaff; Georg Karpel-Massler; Jörg Felsberg; Guido Reifenberger; Marcos Tatagiba; Ghazaleh Tabatabai; Jens Schittenhelm; Christian Thomas; Martin Hasselblatt; Corinna Seliger; Christoph Kleinschnitz; Ulrich Sure; David Capper; Michael Platten; Felix Behling; Michael Müther; Sied Kebir

Affiliations1. Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 2. Division of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 3. Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany; 4. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany; 6. Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; 7. Department of Neurosurgery, Medical Faculty, Center of Neuro-Oncology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; 8. Institute of Neuropathology, University Medicine Essen, Essen, Germany; 9. Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 10. Department of Neurooncology, Centers for Neurology and Integrated Oncology (CIO), University Hospital Bonn, Bonn, Germany; 11. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; 12. Department of Neurosurgery, Universität Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 13. Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 14. Department of Neurological Surgery, Ulm University Medical Center, Ulm, Germany; 15. Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany; 16. Goethe University, Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt Am Main, Germany; 17. German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, a Partnership Between DKFZ and University Hospital Essen, Germany, DKFZ-Division Translational Neuro-Oncology at the West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 18. Medical Oncology, University Hospital Basel, Basel, Switzerland; 19. Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland; 20. Institute for Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland; 21. Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 22. Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 23. Department of Pediatrics III, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital of Essen, Essen, Germany; 24. Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; 25. German Cancer Consortium (DKTK), Essen, Germany; 26. Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, Leipzig, Germany; 27. Institute of Pathology, Ruhr University Bochum, Bochum, Germany; 28. Department of Neurosurgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 29. Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany; 30. Institute of Neuropathology, Medical Faculty, Heinrich-Heine-University Düsseldorf, and University Hospital Düsseldorf, Düsseldorf, Germany; 31. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 32. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard-Karls-University Tübingen, Tübingen, Germany; 33. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 34. Institute of Neuropathology, University Hospital Münster, Münster, Germany; 35. German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 36. Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany; 37. Department of Neurosurgery, Faculty of Medicine, University of Augsburg, Augsburg, Germany; 38. Department of Neurosurgery, University Hospital Münster, Münster, Germany

Source PDF DOI Publisher page
160 days

Overactivation of SHH signaling induces a cascade of dedifferentiation and oncogenesis in a new mouse model for choroid plexus carcinoma

AuthorsLevke-Sophie Peter; Lea Altendorf; Karoline Hack; Vanessa Thaden; Carolin Göbel; Beatrix Mahnke; Christian Krebs; Saskia-L. Jauch-Speer; Uwe R. Kordes; Denise Obrecht-Sturm; Christian Thomas; Ulrich Schüller; Melanie Schoof

Affiliations1. Research Institute Children’s Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2. Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3. III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 4. Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Single Cell Core Facility, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6. Institute of Neuropathology, University Hospital Münster, Münster, Germany; 7. Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 8. Mildred Scheel Cancer Career Centre HaTriCS4, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany

Source PDF DOI Publisher page
72 days

Reduced microvascular coverage links a hypoxia-associated niche to microglial autophagic dysfunction in Parkinson’s disease

AuthorsHualin Wang; Zhuang Zhu; Zefu Yin; Yao Geng; Yihang Xu; Yi Fan; Kezhong Zhang

Affiliations1. Department of Neurology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China; 2. The First School of Clinical Medicine, Nanjing Medical University, Nanjing, China; 3. Rehabilitation Medicine Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, People’s Republic of China; 4. Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China

Source PDF DOI Publisher page
92 days

Immune niches in brain tumors: glial–immune cell interactions and spatial microdomains

AuthorsQian Guo; Sihang Shen; Zhouyuan Zhang; Meirong Shan; Bochen Pan; Xiao Yu; Yi Chen

Affiliations1. Department of Rhinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. School of Acupuncture-Moxibustion and Tuina & School of Health Preservation and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, China; 3. School of Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 4. Department of Geriatrics, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 5. Department of Urology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China; 6. Department of Otolaryngology–Head and Neck Surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. Cancer Research Institute, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China

Source PDF DOI Publisher page
122 days

Amplification of seeding-competent tau aggregates by PMCA in human and experimental tauopathies

AuthorsFlorian Almela; Maxime Belondrade; Raphaelle Caillierez; Sarah Leclercq; Thomas Bouillet; Séverine Bégard; Marie Oosterlynck; Sabiha Eddarkaoui; Susana Boluda; Luc Buée; Simon Nicot; Morvane Colin; Daisy Bougard

Affiliations1. Laboratoire TransDiag, Etablissement Français du Sang, Montpellier, France; 2. Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM, EFS, Montpellier, France; 3. UMR-S1172 Lille Neuroscience & Cognition (LilNCog), University of Lille, Inserm, CHU Lille, Lille, France; 4. Department of Neuropathology, DMU Neuroscience, AP-HP, Paris Brain Institute-ICM, Inserm, CNRS, Hôpital de la Pitié Salpêtrière, Sorbonne University, Paris, France

Source PDF DOI Publisher page
71 days

Overactive EAAT1 Cl − channels impair GABAergic tonic inhibition in SLC1A3 -associated episodic ataxia

AuthorsYulia Kostritskaia; Daniela Bulla-Miely; Miriam Engels; Jan Meyer; Juliane L. Berns; Sabrina Behuet; Sebastian Bludau; Christine R. Rose; Albert Becker; Thomas Gensch; Ulrike B. S. Hedrich; Christoph Fahlke; Peter Kovermann

Affiliations1. Institute of Biological Information Processing, Molekular- und Zellphysiologie (IBI-1), Forschungszentrum Jülich, Jülich, Germany; 2. MSH Medical School Hamburg, Hamburg, Germany; 3. Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; 4. Institute of Neurobiology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany; 5. Institute for Cellular Neurosciences II, Universitätsklinikum Bonn, Bonn, Germany; 6. Institute of Neuroscience and Medicine, Strukturelle und funktionelle Organisation des Gehirns (INM-1), Forschungszentrum Jülich GmbH, Jülich, Germany

Source PDF DOI Publisher page
118 days

Galectin-3 is elevated in Müller glia in human glaucomatous eyes and ocular hypertensive rat eyes and associated with phagocytosing states

AuthorsAnne Rombaut; Luozixian Wang; Emma Lardner; Raymond CB Wong; Charlotte Taul; Miriam Kolko; Gustav Stålhammar; Rune Brautaset; Filippo Locri; Pete A. Williams; James R. Tribble

Affiliations1. Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden; 2. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia; 3. Department of Surgery (Ophthalmology), The University of Melbourne, Melbourne, Australia; 4. Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark; 5. Department of Ophthalmology, Copenhagen University Hospital, Glostrup, Denmark; 6. Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark; 7. Wolfson Sensory, Pain and Regeneration Centre (SPaRC), School of Neuroscience, King’s College London, London, UK

Source PDF DOI Publisher page
88 days

Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma

AuthorsLuisa Voßbeck; Felix Ehret; Eilis Perez; Helena Radbruch; Elisabeth G. Hain; Simone Schmid; Julia Onken; Merten Bohn; Nabiha Salman; Leonille Schweizer; David Capper; Moritz Armbrust; David Kaul

Affiliations1. Department of Radiation Oncology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 2. German Cancer Consortium (DKTK), Partner Site Berlin, A Partnership Between DKFZ and Charité – Universitätsmedizin Berlin, Berlin, Germany; 3. Department of Neuropathology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 4. Department of Neurosurgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany; 5. Institute of Neurology (Edinger Institute), Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany; 6. Department of Radiation Oncology, Health and Medical University Potsdam, Potsdam, Germany; 7. German Cancer Consortium (DKTK), Partner Site Frankfurt, German Cancer Research Center (DKFZ), Heidelberg, Germany; 8. Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany; 9. Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt am Main, Germany

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.